About Nephrology Associates of Northern Virginia, Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Nephrology Associates of Northern Virginia, Inc.
During the past decade, Nephrology Associates of Northern Virginia, Inc. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Nephrology Associates of Northern Virginia, Inc." #1 sponsor was "Keryx Biopharmaceuticals" with 2 trials, followed by "Palladio Biosciences" with 2 trials
sponsored, "Bayer" with 1 trials sponsored, "Chinook Therapeutics U.S., Inc." with 1 trials sponsored and "Ineos Healthcare Limited"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nephrology Associates of Northern Virginia, Inc."
#1 collaborator was "Centessa Pharmaceuticals plc" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Nephrology Associates of Northern Virginia, Inc.
According to Clinical.Site data, the most researched conditions in "Nephrology Associates of Northern Virginia, Inc." are
"ADPKD" (3 trials), "Autosomal Dominant Polycystic Kidney" (2 trials), "Hyperphosphatemia" (2 trials), "Kidney Failure" (2 trials) and "Chronic Kidney Failure" (1 trials). Many other conditions were trialed in "Nephrology Associates of Northern Virginia, Inc." in a lesser frequency.
Clinical Trials Intervention Types at Nephrology Associates of Northern Virginia, Inc.
Most popular intervention types in "Nephrology Associates of Northern Virginia, Inc." are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Lixivaptan" (2 trials), "Atrasentan" (1 trials), "Bardoxolone methyl oral capsule" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nephrology Associates of Northern Virginia, Inc.
The vast majority of trials in "Nephrology Associates of Northern Virginia, Inc." are
10 trials for "All" genders.
Clinical Trials Status at Nephrology Associates of Northern Virginia, Inc.
Currently, there are NaN active trials in "Nephrology Associates of Northern Virginia, Inc.".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Nephrology Associates of Northern Virginia, Inc.,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Nephrology Associates of Northern Virginia, Inc., 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".